Shyamakant Giri, Chief Executive Officer of Gland Pharma, expressed optimism about the company's trajectory: "With the current momentum, we anticipate robust growth in the upcoming quarters." As Gland Pharma executes this expansion plan, it aims to strengthen its position in the injectable pharmaceuticals market and capitalize on the growing demand for GLP-1 therapies
This is dangerous because it sticks to the walls of your blood vessels, producing a disease called arteriosclerosis, narrowing of the coronary arteries and many more
Frequently Asked Questions Is Retatrutide or Tirzepatide better for weight loss
It will be marketed a different product called Wegovy
Similarly, exercise elevates metabolism, causing an increase in the use of oxygen and eventually resulting in oxidative stress 16 , 17
PMID 7060551